Helen C. Adams

Insider Reports History

Location
San Diego, CA
Signature
/s/ Ilya Rachman as Attorney-In-Fact for Helen C. Adams
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Helen C. Adams:

Company Role Class Num Shares Value Price $ Report Date Ownership
Immix Biopharma, Inc. Director Common Stock 174,754 $346,012 $1.98 20 Jun 2025 Direct
Immix Biopharma, Inc. Director Stock Option (Right to Buy) 33,000 20 Jun 2025 Direct
Prometheus Biosciences, Inc. Director Common Stock 0 $108.42 16 Jun 2023 Direct
Prometheus Biosciences, Inc. Director Stock Option (right to buy) 0 16 Jun 2023 Direct

Insider Reports Filed by Helen C. Adams

Symbol Company Period Transactions Value $ Form Type Role Filing Time
IMMX Immix Biopharma, Inc. 20 Jun 2025 1 $0 4 Director 23 Jun 2025, 16:57
IMMX Immix Biopharma, Inc. 11 Jun 2024 1 $0 4 Director 21 Jun 2024, 17:45
IMMX Immix Biopharma, Inc. 15 May 2024 2 $0 4 Director 20 May 2024, 17:25
IMMX Immix Biopharma, Inc. 12 Sep 2023 1 +$38,492 4 Director 14 Sep 2023, 18:20
IMMX Immix Biopharma, Inc. 11 Aug 2023 1 $0 4 Director 14 Aug 2023, 17:15
/report/000089924323015753-adams-helen-c-2023-06-16 Prometheus Biosciences, Inc. 16 Jun 2023 4 $0 4 Director 16 Jun 2023, 16:00
/report/000120919123031170-adams-helen-c-2023-05-19 Prometheus Biosciences, Inc. 19 May 2023 1 $0 4 Director 19 May 2023, 17:38
IMMX Immix Biopharma, Inc. 14 Jul 2022 1 $0 4 Director 18 Jul 2022, 06:10
/report/000120919122031171-adams-helen-c-2022-05-19 Prometheus Biosciences, Inc. 19 May 2022 1 $0 4 Director 20 May 2022, 19:18
IMMX Immix Biopharma, Inc. 15 Dec 2021 0 $0 3 Director 15 Dec 2021, 20:03
/report/000120919121064940-adams-helen-c-2021-11-14 Prometheus Biosciences, Inc. 14 Nov 2021 1 $0 4 Director 16 Nov 2021, 20:17